Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others

CASE REPORT

Dasatinib-induced pleural effusion: Chylothorax, an option to consider

Ferreiro Lucia, San-Jose Esther, Suarez-Antelo Juan, Valdes Luis

Year : 2016| Volume: 11| Issue : 4 | Page no: 289-293

   This article has been cited by
 
1 Dasatinib-induced massive left chylothorax in a patient with chronic myeloid leukemia
Go Makimoto, Mahito Misawa, Yoshinobu Maeda, Katsuyuki Kiura
Respiratory Medicine Case Reports. 2022; : 101662
[Pubmed]  [Google Scholar] [DOI]
2 Dasatinib-Induced Bilateral Pleural Effusions
Taha F Rasul, Gabriel Motoa, Robert C Flowers
Cureus. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Zahra Nekoukar, Minoo Moghimi, Ebrahim Salehifar
BLOOD RESEARCH. 2021; 56(4): 229
[Pubmed]  [Google Scholar] [DOI]
4 Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review
Chao-Chin Hsu, Jui-Feng Hsu, Kuan-Li Wu
Respirology Case Reports. 2021; 9(6)
[Pubmed]  [Google Scholar] [DOI]
5 Dasatinib-induced chylothorax: report of a case and review of the literature
Bojiang Chen, Zuohong Wu, Qin Wang, Weimin Li, Deyun Cheng
Investigational New Drugs. 2020; 38(5): 1627
[Pubmed]  [Google Scholar] [DOI]
6 Dasatinib as a Probable Cause of Bilateral Chylothorax in a Patient with Chronic Myeloid Leukemia: Case Report
Sze Shyang Kho, Larry Ellee Nyanti, Chan Sin Chai, Siew Teck Tie
SN Comprehensive Clinical Medicine. 2020; 2(6): 817
[Pubmed]  [Google Scholar] [DOI]
7 Chylothorax secondary to dasatinib
Virginia Molina, Sandra Vañes, Carmen Castelló, Eusebi Chiner
Archivos de Bronconeumología (English Edition). 2020; 56(9): 599
[Pubmed]  [Google Scholar] [DOI]
8 Quilotórax espontáneo secundario a dasatinib
Virginia Molina, Sandra Vañes, Carmen Castelló, Eusebi Chiner
Archivos de Bronconeumología. 2020; 56(9): 599
[Pubmed]  [Google Scholar] [DOI]
9 Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature
Kyle Hickman, Elizabeth Diaz, Robert Graham, Roberta Adams, Alex Ngwube
Journal of Pediatric Hematology/Oncology. 2020; 42(7): e665
[Pubmed]  [Google Scholar] [DOI]
10 Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors
Jason Weatherald, Louise Bondeelle, Marie-Camille Chaumais, Christophe Guignabert, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Philippe Rousselot, Marc Humbert, Anne Bergeron, David Montani
European Respiratory Journal. 2020; 56(4): 2000279
[Pubmed]  [Google Scholar] [DOI]
11 Dasatinib-Induced Lymphocytosis and Pleural Effusion in a Patient of Chronic Myeloid Leukemia: A Rare Indian Case Report
Ashish Joshi, Reshma Korgavkar, Kshitij Joshi, Vashishth Maniar, Pritam Kalaskar, Pradip Kendre, Kunal Sehgal, Neha Seth
Indian Journal of Medical and Paediatric Oncology. 2020; 41(03): 436
[Pubmed]  [Google Scholar] [DOI]
12 Tyrosine Kinase Inhibitor–associated Fibrothorax
Andres M. Adrianza, Carlos A. Jimenez, Grecia L. Aldana, Leonardo Pozo, Jorge E. Cortes, Ala Eddin S. Sagar
American Journal of Respiratory and Critical Care Medicine. 2019; 199(11): 1432
[Pubmed]  [Google Scholar] [DOI]

 

Read this article